Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions

Author： Jhaveri Komal   Ochiana Stefan O   Dunphy Mark PS   Gerecitano John F   Corben Adriana D   Peter Radu I   Janjigian Yelena Y   Gomes-DaGama Erica M   Koren John   Modi Shanu   Chiosis Gabriela  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.23, Iss.5, 2014-05, pp. : 611-628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment

By Patel Hardik J   Modi Shanu   Chiosis Gabriela   Taldone Tony  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 559-587

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics – an update

By Neckers Len   Neckers Katharine  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 137-149

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents

By Neckers Len   Neckers Katharine  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 277-288

Informa Healthcare

Access to resources Recommend Favorite

The Clinical Applications of Heat Shock Protein Inhibitors in Cancer - Present and Future

By  

Current Cancer Drug Targets, Vol. 3, Iss. 5, 2003-10 ,pp. : 385-390

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the Immunoproteasome: Current Status and Future Directions

By  

Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-07 ,pp. : 4140-4151

Bentham Science Publishers

Access to resources Recommend Favorite